1. Varki, A. (2008): Sialic acids in human health and Disease. Trends Mol. Med. 14: 351-360.
2. Sakul, A.; Cumaoglu, A.; Aydın, E.; Ar, N.; Dilsiz, N. and Karasu, C. (2013): Age- and diabetes-induced regulation of oxidative protein modification in rat brain and peripheral tissues: Consequences of treatment with antioxidant pyridoindole. Exp. Gerontol. 48: 476-484.
3. Savini, I.; Catani, M. V.; Evangelista, D.; Gasperi, V. and Avigliano, L. (2013): Obesity-associated oxidative stress: strategies finalized to improve redox state. Int. J. Mol. Sci. 14: 10497-10538.
4. Bansal, S.; Chawla, D.; Siddarth, M.; Banerjee, B. D.; Madhu, S. V. and Tripathi, A. K. (2013): A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications. Clin. Biochem. 46: 109-114
5. Samatha, P.; Venkateswarlu, M. and Siva Prabodh, V. (2012): Lipid Profile Levels in Type 2 Diabetes Mellitus from the Tribal Population of Adilabad in Andhra Pradesh, India. J. Clin. Diagn. Res. 6: 590-592.
6. Schiffrin, E. L. (2010): Antioxidants in Hypertension and Cardiovascular Disease, Mol. Interv. 10: 354-362.
7. Catanzaroa, O.; Capponia, J. A.; Michielia, J.; Labala, E.; Martinoa, I. D. and Sirois, P. (2013): Bradykinin B1 antagonism inhibits oxidative stress and restores Na+K+ ATPase activity in diabetic rat peripheral nervous system. Peptides. 44: 100- 104.
8. Pazdro, R. and Burgess, J. R. (2010): The role of vitamin E and oxidative stress in diabetes complications. Mech. Ageing Dev. 131: 276-286.